Literature DB >> 28631048

Celiac disease: from etiological factors to evolving diagnostic approaches.

Anantdeep Kaur1, Olga Shimoni2, Michael Wallach3.   

Abstract

Celiac disease has advanced from a medical rarity to a highly prevalent disorder. Patients with the disease show varying degrees of chronic inflammation within the small intestine due to an aberrant immune response to the digestion of gliadin found in wheat. As a result, cytokines and antibodies are produced in celiac patients that can be used as specific biomarkers for developing diagnostic tests. This review paper describes celiac disease in terms of its etiological cause, pathological effects, current diagnostic tests based on mucosal biopsy, and the genetic basis for the disease. In addition, it discusses the use of gliadin-induced cytokines, antibodies and autoantibodies as a diagnostic tool for celiac disease. Despite good initial results in terms of sensitivity and specificity, when these immunological tests were used on a large scale, even in combination with genetic testing, the results showed lower predictive value. This review addresses that issue and ends with an outlook on future work required to develop diagnostic tests with greater accuracy in predicting celiac disease in the general public, thus avoiding the need for endoscopy and mucosal biopsy.

Entities:  

Keywords:  Autoantibodies; Autoimmunity; Celiac disease; Diagnostics

Mesh:

Substances:

Year:  2017        PMID: 28631048     DOI: 10.1007/s00535-017-1357-7

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  103 in total

1.  Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice.

Authors:  K Rostami; J Kerckhaert; R Tiemessen; B M von Blomberg; J W Meijer; C J Mulder
Journal:  Am J Gastroenterol       Date:  1999-04       Impact factor: 10.864

Review 2.  Update on serologic testing in celiac disease.

Authors:  Daniel A Leffler; Detlef Schuppan
Journal:  Am J Gastroenterol       Date:  2010-12       Impact factor: 10.864

3.  A novel saliva-based microRNA biomarker panel to detect head and neck cancers.

Authors:  Carolina Salazar; Rahul Nagadia; Pratibala Pandit; Justin Cooper-White; Nilanjana Banerjee; Nevenka Dimitrova; William B Coman; Chamindie Punyadeera
Journal:  Cell Oncol (Dordr)       Date:  2014-08-26       Impact factor: 6.730

4.  Measurement of gastrointestinal pH profiles in normal ambulant human subjects.

Authors:  D F Evans; G Pye; R Bramley; A G Clark; T J Dyson; J D Hardcastle
Journal:  Gut       Date:  1988-08       Impact factor: 23.059

5.  Anti-tissue transglutaminase, anti-endomysium and anti-R1-reticulin autoantibodies-the antibody trinity of coeliac disease.

Authors:  R J Lock; J E Gilmour; D J Unsworth
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

6.  Salivary IgA antigliadin antibody as a marker for coeliac disease.

Authors:  V Hakeem; R Fifield; H F al-Bayaty; M J Aldred; D M Walker; J Williams; H R Jenkins
Journal:  Arch Dis Child       Date:  1992-06       Impact factor: 3.791

7.  Endomysial antibodies predict celiac disease irrespective of the titers or clinical presentation.

Authors:  Kalle Kurppa; Tiia Räsänen; Pekka Collin; Sari Iltanen; Heini Huhtala; Merja Ashorn; Päivi Saavalainen; Katri Haimila; Jukka Partanen; Markku Mäki; Katri Kaukinen
Journal:  World J Gastroenterol       Date:  2012-05-28       Impact factor: 5.742

8.  Serologic assay based on gliadin-related nonapeptides as a highly sensitive and specific diagnostic aid in celiac disease.

Authors:  Elke Schwertz; Franka Kahlenberg; Ulrich Sack; Thomas Richter; Martin Stern; Karsten Conrad; Klaus-Peter Zimmer; Thomas Mothes
Journal:  Clin Chem       Date:  2004-10-07       Impact factor: 8.327

9.  Endomysium antibodies in coeliac disease: an improved method.

Authors:  B Ladinser; E Rossipal; K Pittschieler
Journal:  Gut       Date:  1994-06       Impact factor: 23.059

10.  Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients.

Authors:  K E Lundin; H Scott; T Hansen; G Paulsen; T S Halstensen; O Fausa; E Thorsby; L M Sollid
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more
  3 in total

Review 1.  An Overview of Celiac Disease in Childhood Type 1 Diabetes.

Authors:  Iraj Shahramian; Ali Bazi; Alireza Sargazi
Journal:  Int J Endocrinol Metab       Date:  2018-06-27

2.  Combination of Gluten-Digesting Enzymes Improved Symptoms of Non-Celiac Gluten Sensitivity: A Randomized Single-blind, Placebo-controlled Crossover Study.

Authors:  Hiroki Ido; Hirotaka Matsubara; Manabu Kuroda; Akiko Takahashi; Yuzo Kojima; Satoshi Koikeda; Makoto Sasaki
Journal:  Clin Transl Gastroenterol       Date:  2018-09-19       Impact factor: 4.488

3.  Role of IL-24 in the mucosal remodeling of children with coeliac disease.

Authors:  Réka Rokonay; Apor Veres-Székely; Beáta Szebeni; Domonkos Pap; Rita Lippai; Nóra J Béres; Gábor Veres; Attila J Szabó; Ádám Vannay
Journal:  J Transl Med       Date:  2020-01-23       Impact factor: 5.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.